Takeda may be close to Japanese OTC sale
Premium
22 June 2020
Takeda may be close to divesting its Japanese OTC business, Takeda Consumer Healthcare Company, according to media reports.
Industry News - Tag: Takeda
You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
Takeda may be close to Japanese OTC sale
South Korea’s Celltrion to acquire Takeda portfolio
Premium
15 June 2020
South Korean biopharmaceutical company Celltrion is acquiring a portfolio of prescription and OTC brands from Japan’s Takeda in a deal worth up to USD278 million.
Orifarm gains OTC business through Takeda deal
Premium
24 April 2020
Danish pharmaceutical company Orifarm is acquiring a portfolio of OTC and prescription pharmaceuticals sold in Europe from Japan’s Takeda in a deal worth up to approximately USD670 million.
Hypera strikes 'transformational' Takeda deal
Premium
5 March 2020
Brazil’s Hypera Pharma is strengthening its presence in Latin America by acquiring a portfolio of OTC and pharmaceutical products – including the Neosaldina brand – from Japan’s Takeda for USD825 million. The deal comes soon after Hypera announced the purchase of the Buscopan and Buscofem brands in...
Stada to acquire Takeda OTC portfolio for USD660 mn
Premium
5 November 2019
Stada Arzneimittel is acquiring Takeda’s OTC portfolio in Russia and the Commonwealth of Independent States (CIS) in a deal worth USD660 million. The deal comes a day after the German company announced it was purchasing Czech consumer healthcare firm Walmark.
Acino snaps up portfolio of products from Takeda
Premium
16 October 2019
Switzerland’s Acino is acquiring a portfolio of OTC and prescription pharmaceuticals from Japan’s Takeda in a deal worth more than USD200 million.